On June 12th, Hua Hong Pharmaceutical rose more than 10%, previously reached limit up by Lionco Pharmaceutical Group, Hisoar Pharmaceutical, Jiangxi Synergy Pharmaceutical, Haoyuan Medicine, Pharmaron, Guangxi Hechi Chemical, Haoyuan Medicine, Jiangxi Fushine Pharmaceutical, Sailong Pharmaceutical Group, and WuXi AppTec were among the top gainers.
A股医药股走高 CRO方向领涨
Medical related stocks in A-shares have risen, with CRO direction leading the way.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.